Wows.._老虎社区_美港股上老虎

2021-10-06

Wows..

Ocugen Stock Up on Development Pact for Covid Vaccine Candidate

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":829943411,"tweetId":"829943411","gmtCreate":1633466512192,"gmtModify":1633466512500,"author":{"id":3575640395742421,"idStr":"3575640395742421","authorId":3575640395742421,"authorIdStr":"3575640395742421","name":"ccmk","avatar":"https://static.tigerbbs.com/a90d67ad1fb38a136eae07512ce11d0f","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":15,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Wows..&nbsp;</p></body></html>","htmlText":"<html><head></head><body><p>Wows..&nbsp;</p></body></html>","text":"Wows..","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/829943411","repostId":1173343014,"repostType":4,"repost":{"id":"1173343014","kind":"news","pubTimestamp":1633444442,"share":"https://www.laohu8.com/m/news/1173343014?lang=&edition=full","pubTime":"2021-10-05 22:34","market":"us","language":"en","title":"Ocugen Stock Up on Development Pact for Covid Vaccine Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1173343014","media":"Thestreet","summary":"Shares of Ocugen (OCGN) jumped after the drugmaker said it entered a development-and-supply agreemen","content":"<p>Shares of Ocugen&nbsp;(<b>OCGN</b>)&nbsp;jumped after the&nbsp;drugmaker said it entered a development-and-supply agreement with Bharat Biotech tied to Ocugen's Covid-19 vaccine candidate.</p>\n<p>In a Securities and Exchange Commission 8K filing, Ocugen said Bharat will supply it with clinical-trial materials and, if the drug is cleared by regulators, commercial supplies of finished drug product and drug components.</p>\n<p>Shares of Ocugen, Malvern, Pa., at last check were 7% higher at $7.22. Bharat is the Hyderabad, India, biotechnology company.</p>\n<p>Ocugen also said in the SEC filing that it entered an amended accord with development partner CanSino Biologics. The agreement is tied to Ocugen's gene-therapy candidate, OCU410, to treat dry age-related macular degeneration.</p>\n<p>Under the amended accord, the companies will collaborate to develop OCU410. CanSino, the Tianjin, China, vaccine producer, will be responsible for the chemistry, manufacturing and controls of the clinical supplies.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ocugen Stock Up on Development Pact for Covid Vaccine Candidate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOcugen Stock Up on Development Pact for Covid Vaccine Candidate\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-05 22:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/ocugen-jumps-covid-vaccine-development-deal><strong>Thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Ocugen (OCGN) jumped after the drugmaker said it entered a development-and-supply agreement with Bharat Biotech tied to Ocugen's Covid-19 vaccine candidate.\nIn a Securities and Exchange ...</p>\n\n<a href=\"https://www.thestreet.com/investing/ocugen-jumps-covid-vaccine-development-deal\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"OCGN":"Ocugen"},"source_url":"https://www.thestreet.com/investing/ocugen-jumps-covid-vaccine-development-deal","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173343014","content_text":"Shares of Ocugen (OCGN) jumped after the drugmaker said it entered a development-and-supply agreement with Bharat Biotech tied to Ocugen's Covid-19 vaccine candidate.\nIn a Securities and Exchange Commission 8K filing, Ocugen said Bharat will supply it with clinical-trial materials and, if the drug is cleared by regulators, commercial supplies of finished drug product and drug components.\nShares of Ocugen, Malvern, Pa., at last check were 7% higher at $7.22. Bharat is the Hyderabad, India, biotechnology company.\nOcugen also said in the SEC filing that it entered an amended accord with development partner CanSino Biologics. The agreement is tied to Ocugen's gene-therapy candidate, OCU410, to treat dry age-related macular degeneration.\nUnder the amended accord, the companies will collaborate to develop OCU410. CanSino, the Tianjin, China, vaccine producer, will be responsible for the chemistry, manufacturing and controls of the clinical supplies.","news_type":1},"isVote":1,"tweetType":1,"viewCount":205,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":6,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/829943411"}